A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
- PMID: 34493870
- PMCID: PMC10243600
- DOI: 10.1038/s41588-021-00921-z
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
Erratum in
-
Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.Nat Genet. 2021 Dec;53(12):1722. doi: 10.1038/s41588-021-00977-x. Nat Genet. 2021. PMID: 34773122 No abstract available.
-
Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.Nat Genet. 2022 Jul;54(7):1062. doi: 10.1038/s41588-022-01126-8. Nat Genet. 2022. PMID: 35726068 No abstract available.
Abstract
Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing Interests Statement
All other authors declare no competing interests.
Figures

Comment in
-
Genome-wide association study identifies new risk loci for Alzheimer disease.Nat Rev Neurol. 2021 Nov;17(11):659. doi: 10.1038/s41582-021-00575-9. Nat Rev Neurol. 2021. PMID: 34599319 No abstract available.
Similar articles
-
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's disease.Neurobiol Aging. 2021 May;101:299.e13-299.e21. doi: 10.1016/j.neurobiolaging.2020.11.009. Epub 2020 Nov 12. Neurobiol Aging. 2021. PMID: 33303219
-
Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume.Brain Behav Immun. 2019 Jul;79:267-273. doi: 10.1016/j.bbi.2019.02.011. Epub 2019 Feb 15. Brain Behav Immun. 2019. PMID: 30776473 Free PMC article.
-
Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.Genes (Basel). 2020 May 2;11(5):501. doi: 10.3390/genes11050501. Genes (Basel). 2020. PMID: 32370229 Free PMC article.
-
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.Lancet Neurol. 2020 Apr;19(4):326-335. doi: 10.1016/S1474-4422(19)30435-1. Epub 2020 Jan 24. Lancet Neurol. 2020. PMID: 31986256 Free PMC article. Review.
-
From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.J Alzheimers Dis. 2020;74(4):1271-1283. doi: 10.3233/JAD-191233. J Alzheimers Dis. 2020. PMID: 32250305 Free PMC article.
Cited by
-
The intricate interplay between microglia and adult neurogenesis in Alzheimer's disease.Front Cell Neurosci. 2024 Sep 18;18:1456253. doi: 10.3389/fncel.2024.1456253. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39360265 Free PMC article. Review.
-
Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease.Front Immunol. 2024 Jan 29;15:1323409. doi: 10.3389/fimmu.2024.1323409. eCollection 2024. Front Immunol. 2024. PMID: 38352874 Free PMC article.
-
Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types.Adv Neurobiol. 2024;37:531-544. doi: 10.1007/978-3-031-55529-9_29. Adv Neurobiol. 2024. PMID: 39207711 Review.
-
Identification and Quantitation of Novel ABI3 Isoforms Relative to Alzheimer's Disease Genetics and Neuropathology.Genes (Basel). 2022 Sep 8;13(9):1607. doi: 10.3390/genes13091607. Genes (Basel). 2022. PMID: 36140776 Free PMC article.
-
Prioritizing disease-related rare variants by integrating gene expression data.PLoS Genet. 2024 Sep 30;20(9):e1011412. doi: 10.1371/journal.pgen.1011412. eCollection 2024 Sep. PLoS Genet. 2024. PMID: 39348415 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG054076/AG/NIA NIH HHS/United States
- MC_PC_17214/MRC_/Medical Research Council/United Kingdom
- U24 AG021886/AG/NIA NIH HHS/United States
- U24 AG072122/AG/NIA NIH HHS/United States
- U01 AG032984/AG/NIA NIH HHS/United States
- R01 AG028555/AG/NIA NIH HHS/United States
- R01 AG017561/AG/NIA NIH HHS/United States
- R01 AG033193/AG/NIA NIH HHS/United States
- R01 AG060470/AG/NIA NIH HHS/United States
- 082604/2/07/Z/WT_/Wellcome Trust/United Kingdom
- P50 HD103537/HD/NICHD NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 AG016976/AG/NIA NIH HHS/United States
- R01 AG008724/AG/NIA NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- 503480/MRC_/Medical Research Council/United Kingdom
- P30 AG066546/AG/NIA NIH HHS/United States
- U01 AG052409/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical